PCR

News on qPCR, digital PCR, amplification, point-of-care testing platforms in genetics, genomics, and molecular diagnostics.

The firm raised €4.7 million through a conditional placement, and €5.0 million through an unconditional direct subscription.

Demand for the BioFire FilmArray panels continued to drive sales in the firm's molecular biology business.

The recent study highlights strengths and weaknesses of numerous platforms and may help end users choose the best assay for their circumstances.

The test detects and differentiates respiratory syncytial virus and human metapneumovirus on the firm's Solana rapid molecular platform.

The two companies plan to secure required initial regulatory approvals in individual African territories before expanding to other areas in the region.